AI assistant
OMNICELL, INC. — Director's Dealing 2025
Mar 18, 2025
31980_dirs_2025-03-18_41bc2b3a-bc60-4286-bdae-dcacab8c3327.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2025-03-14
Reporting Person: LIPPS RANDALL A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-14 | Common Stock | P | 10561 | $33.1289 | Acquired | 333610 | Direct |
| 2025-03-15 | Common Stock | A | 79494 | — | Acquired | 413104 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 355861 | Indirect |
| Common Stock | 8051 | Indirect |
Footnotes
F1: Shares held in trust with Mr. Lipps' wife.
F2: Shares held in trust for the benefit of Mr. Lipps' children.
F3: The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15.